Granahan Investment Management - AGILE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Granahan Investment Management ownership history of AGILE THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$566,000
-78.2%
99,225
-73.3%
0.02%
-77.6%
Q3 2016$2,599,000
-6.5%
372,326
+1.9%
0.08%
-15.8%
Q2 2016$2,781,000
+19.0%
365,416
-2.9%
0.10%
+18.8%
Q1 2016$2,336,000
-38.5%
376,196
-3.4%
0.08%
-35.1%
Q4 2015$3,801,000
+189.3%
389,486
+99.8%
0.13%
+219.5%
Q3 2015$1,314,000
-13.7%
194,894
+10.0%
0.04%
-4.7%
Q2 2015$1,522,000
-9.8%
177,150
-2.7%
0.04%
-10.4%
Q1 2015$1,687,000182,0200.05%
Other shareholders
AGILE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Perceptive Advisors 15,919,925$15,301,0000.22%
NEEDHAM INVESTMENT MANAGEMENT LLC 735,000$706,0000.09%
INVESTOR AB 3,510,189$3,370,0000.09%
GSA CAPITAL PARTNERS LLP 586,491$564,0000.06%
FIRST MIDWEST BANK TRUST DIVISION 335,735$322,0000.05%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 70,000$67,0000.02%
Summit Global Investments 126,000$121,0000.01%
Ergoteles LLC 211,611$203,0000.01%
Centric Wealth Management 10,000$10,0000.00%
GRIMES & COMPANY, INC. 99,744$96,0000.00%
View complete list of AGILE THERAPEUTICS INC shareholders